Skip to content
← Full study record

NCT00918333 · MORE INFO

Limitations, agreements, and source contact

Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma · Source last updated 2020-03-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
Kumar.shaji@mayo.edu
organization
Mayo Clinic Cancer Center
phone
507-284-2511
title
Shaji Kumar, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
Kumar.shaji@mayo.edu
organization
Mayo Clinic Cancer Center
phone
507-284-2511
title
Shaji Kumar, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice